Literature DB >> 17437583

Electrical cardioversion for AF-the state of the art.

Nicholas P Gall1, Francis D Murgatroyd.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17437583     DOI: 10.1111/j.1540-8159.2007.00709.x

Source DB:  PubMed          Journal:  Pacing Clin Electrophysiol        ISSN: 0147-8389            Impact factor:   1.976


× No keyword cloud information.
  7 in total

1.  Responsiveness of AF6, a new, short, validated, atrial fibrillation-specific questionnaire--symptomatic benefit of direct current cardioversion.

Authors:  Marie Härdén; Britta Nyström; Ann Bengtson; Jennie Medin; Lars Frison; Nils Edvardsson
Journal:  J Interv Card Electrophysiol       Date:  2010-05-12       Impact factor: 1.900

2.  A non-invasive method to predict electrical cardioversion outcome of persistent atrial fibrillation.

Authors:  Raúl Alcaraz; José Joaquín Rieta
Journal:  Med Biol Eng Comput       Date:  2008-04-24       Impact factor: 2.602

3.  Non-invasive atrial fibrillation organization follow-up under successive attempts of electrical cardioversion.

Authors:  Raúl Alcaraz; José Joaquín Rieta; Fernando Hornero
Journal:  Med Biol Eng Comput       Date:  2009-12       Impact factor: 2.602

4.  Natriuretic Peptides as Predictors of Atrial Fibrillation Recurrences Following Electrical Cardioversion.

Authors:  Theodoros A Zografos; Demosthenes G Katritsis
Journal:  Arrhythm Electrophysiol Rev       Date:  2013-11-29

5.  Central tendency measure and wavelet transform combined in the non-invasive analysis of atrial fibrillation recordings.

Authors:  Raúl Alcaraz; José Joaquín Rieta
Journal:  Biomed Eng Online       Date:  2012-08-09       Impact factor: 2.819

6.  Application of Wavelet Entropy to predict atrial fibrillation progression from the surface ECG.

Authors:  Raúl Alcaraz; José J Rieta
Journal:  Comput Math Methods Med       Date:  2012-09-26       Impact factor: 2.238

Review 7.  Electrical cardioversion.

Authors:  Murat Sucu; Vedat Davutoglu; Orhan Ozer
Journal:  Ann Saudi Med       Date:  2009 May-Jun       Impact factor: 1.526

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.